News

Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Regulatory news - September 2018Regulatory news - September 2018Regulatory news - August 2018Regulatory news - August 2018August news: Catapult network granted £780m in additional fundingAugust news: Catapult network granted £780m in additional fundingFlagship EU Programme in Advanced Therapies Moves into New Round of FundingFlagship EU Programme in Advanced Therapies Moves into New Round of FundingUK Government Grants Catapult Network £780M in Additional FundingUK Government Grants Catapult Network £780M in Additional FundingAnnual Review 2018 highlights work of the Cell and Gene Therapy Catapult in building the world’s most complete advanced therapies ecosystemAnnual Review 2018 highlights work of the Cell and Gene Therapy Catapult in building the world’s most complete advanced therapies ecosystemRegulatory news - July 2018Regulatory news - July 2018July news: Stevenage cluster supporting company and industry growthJuly news: Stevenage cluster supporting company and industry growthCGT Catapult granted £3.36m to support increased capacity at Stevenage manufacturing centreCGT Catapult granted £3.36m to support increased capacity at Stevenage manufacturing centreRegulatory news - June 2018Regulatory news - June 2018June news: New CSO wants to place CGT Catapult at the forefront of translational researchJune news: New CSO wants to place CGT Catapult at the forefront of translational researchRegMedNet interview with Jonathan ApplebyRegMedNet interview with Jonathan Appleby